<DOC>
	<DOCNO>NCT03078010</DOCNO>
	<brief_summary>The purpose study see different antibiotic affect community friendly bacteria exist intestinal tract ( gut ) . Under normal circumstance , friendly bacteria harmful help normal bodily function digestion . When bacteria absent , several complication may occur , infection harmful bacteria inflammatory reaction , complicate stem cell transplant course . Treatment antibiotic chemotherapy know kill friendly bacteria . In study compare effect different antibiotic community friendly bacteria gut .</brief_summary>
	<brief_title>Choosing Best Antibiotic Protect Friendly Gut Bacteria During Course Stem Cell Transplant</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Age ≥ 18 year Patients hematologic malignancy undergo unmodified allogeneic HCT Patients must relate unrelated marrow peripheral blood stem cell ( PBSC ) donor follow : A . Sibling donor must 6/6 match HLAA B intermediate ( high ) resolution , HLADRB1 high resolution use DNAbased type B . Unrelated donor must 8/8 match HLAA , B , C DRB1 high resolution use DNAbased typing . Patients hematologic malignancy undergo double umbilical cord blood transplantation without infusion Tcell deplete HLAhaploidentical peripheral blood stem cell . Patients severe allergy piperacillintazobactam cefepime aztreonam . Severe reaction include anaphylaxis StevensJohnson syndrome ( SJS ) /toxic epidermal necrolysis ( TEN ) . Patients unconfirmed allergy piperacillintazobactam , cefepime aztreonam consider Allergy/Immunology referral , outpatient evaluation Dr. Tim Mainardi , may become eligible clearance Allergy/Immunology specialist . Prolonged antibiotic treatment ( ≥10 day , within 3 week enrollment ) prevention suppression ongoing infection , treatment involve gutperturbing anti anaerobic antibiotic Patients know colonized multidrug resistant organisms history infection multidrug resistant organism . Patients history infection extendedspectrum betalactamase produce organism . Febrile patient Patients estimate glomerular filtration rate ( eGFR ) &lt; 30 mL/min/1.73m^2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Antibiotic</keyword>
	<keyword>piperacillin-tazobactam</keyword>
	<keyword>cefepime</keyword>
	<keyword>aztreonam</keyword>
	<keyword>17-097</keyword>
</DOC>